Developing iPSC-derived MSC-based therapies: an interview with Ross Macdonald, Cynata Therapeutics
In this interview from the World Stem Cell Summit (22–26 January, Miami, FL, USA), Ross Macdonald discusses the advantages of MSC-based cell therapies.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.